Ryan Specialty Holdings, Inc. (NYSE:RYAN) Shares Sold by Cumberland Partners Ltd

Cumberland Partners Ltd reduced its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 13.6% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 19,000 shares of the company’s stock after selling 3,000 shares during the period. Cumberland Partners Ltd’s holdings in Ryan Specialty were worth $1,219,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Hollencrest Capital Management purchased a new stake in shares of Ryan Specialty in the third quarter valued at $25,000. Assetmark Inc. acquired a new stake in Ryan Specialty in the 3rd quarter worth about $34,000. Principal Securities Inc. grew its holdings in Ryan Specialty by 164.7% in the 4th quarter. Principal Securities Inc. now owns 667 shares of the company’s stock valued at $43,000 after buying an additional 415 shares during the period. Quarry LP lifted its holdings in shares of Ryan Specialty by 109.3% during the 3rd quarter. Quarry LP now owns 808 shares of the company’s stock worth $54,000 after acquiring an additional 422 shares during the period. Finally, Signaturefd LLC boosted its position in shares of Ryan Specialty by 12.3% in the third quarter. Signaturefd LLC now owns 1,347 shares of the company’s stock worth $89,000 after acquiring an additional 148 shares during the last quarter. 84.82% of the stock is currently owned by institutional investors and hedge funds.

Ryan Specialty Stock Down 0.3 %

NYSE RYAN opened at $69.38 on Thursday. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a fifty-two week low of $45.55 and a fifty-two week high of $75.97. The business has a 50 day moving average price of $65.58 and a two-hundred day moving average price of $67.25. The stock has a market cap of $18.17 billion, a PE ratio of 90.11, a P/E/G ratio of 1.21 and a beta of 0.72.

Insider Activity

In other news, Director Nicholas Dominic Cortezi sold 29,466 shares of Ryan Specialty stock in a transaction dated Monday, January 13th. The stock was sold at an average price of $65.06, for a total transaction of $1,917,057.96. Following the sale, the director now directly owns 45,409 shares of the company’s stock, valued at approximately $2,954,309.54. The trade was a 39.35 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Over the last three months, insiders sold 316,451 shares of company stock worth $20,907,793. 11.10% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

RYAN has been the subject of several research analyst reports. Barclays upped their price target on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research report on Thursday, November 21st. Keefe, Bruyette & Woods cut their target price on Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating on the stock in a research report on Friday, January 10th. Morgan Stanley initiated coverage on Ryan Specialty in a research report on Thursday, December 5th. They set an “overweight” rating and a $90.00 price target for the company. Finally, Wells Fargo & Company cut their price objective on Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating on the stock in a report on Tuesday, January 14th. One research analyst has rated the stock with a sell rating, five have given a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $74.40.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.